Cart
sales@molnova.com
ZY-444
CAS No. 1802650-31-2
ZY-444( —— )
Catalog No. M35658 CAS No. 1802650-31-2
ZY-444 is a small molecule inhibiting the progression of breast cancer by targeting pyruvate carboxylase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 202 | In Stock |
|
| 10MG | 297 | In Stock |
|
| 25MG | 629 | In Stock |
|
| 50MG | 926 | In Stock |
|
| 100MG | 1693 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZY-444
-
NoteResearch use only, not for human use.
-
Brief DescriptionZY-444 is a small molecule inhibiting the progression of breast cancer by targeting pyruvate carboxylase.
-
DescriptionZY-444 is a small molecule that suppresses breast cancer progression by targeting pyruvate carboxylase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1802650-31-2
-
Formula Weight444.59
-
Molecular FormulaC26H28N4OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (224.93 mM; Ultrasonic )
-
SMILESN=1C=CC(=NC1NCC(C)C)NCC=2SC(=CC2)C=3C=CC(OCC=4C=CC=CC4)=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lin Q, et al. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Adv Sci (Weinh). 2020 Mar 12;7(9):1903483.?
molnova catalog
related products
-
[D-Ala2, DArg6] Dyno...
[D-Ala2, DArg6] Dynorphin A, (1-13), porcine
-
Cixutumumab
Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling.
-
[pSer2, pSer5, pSer7...
[pSer2, pSer5, pSer7]-CTD (TFA) is a substrate for CDK7(cyclin-dependent protein kinase), a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD).
